100% Quality Guarantee
PhD-Level Technical Support
Key Features

Purified Anti-Human CD279/PD-1 Antibody [J110] (AGEL2401)

SKU AGEL2401
Product Type Antibody
Antibody Type Monoclonal Antibody
Applications FCM
Reactivity Human
Host Species Mouse
Isotype Mouse IgG1, κ
Clone J110
Conjugation Unconjugated
€25 - €63

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Purified Anti-Human CD279/PD-1 Antibody [J110]

The Purified Anti-Human CD279 (PD-1) Antibody J110 is a cutting-edge tool for researchers studying immune checkpoint molecules in the context of immunotherapy and cancer research. This monoclonal antibody specifically targets CD279 (PD-1), a crucial regulator of T cell activation and tolerance.Developed using advanced purification techniques, this antibody offers high specificity and sensitivity in detecting human CD279 (PD-1) protein expression. It is validated for use in various applications including flow cytometry, immunohistochemistry, and immunofluorescence, providing researchers with versatile options for elucidating the role of CD279 in immune responses and tumor evasion mechanisms.

CD279 (PD-1) has emerged as a key target for novel cancer therapies, as its interaction with ligands such as PD-L1 can suppress anti-tumor immune responses. By utilizing this antibody, researchers can investigate the expression levels and localization of CD279 in tumor microenvironments, paving the way for the development of more effective immunotherapeutic strategies.For researchers seeking to unravel the complexities of immune checkpoint pathways and explore innovative treatment modalities in oncology, the Purified Anti-Human CD279 (PD-1) Antibody J110 represents a valuable ally in advancing scientific understanding and clinical outcomes.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose